133 related articles for article (PubMed ID: 3613881)
1. Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long-term follow-up study.
Bentsen KD; Hørslev-Petersen K; Junker P; Juhl E; Lorenzen I
Liver; 1987 Apr; 7(2):96-105. PubMed ID: 3613881
[TBL] [Abstract][Full Text] [Related]
2. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity.
Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z
Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636
[TBL] [Abstract][Full Text] [Related]
3. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
[TBL] [Abstract][Full Text] [Related]
4. Persistent elevation of the aminoterminal peptide of procollagen type III in serum of patients with acute viral hepatitis distinguishes chronic active hepatitis from resolving or chronic persistent hepatitis.
Annoni G; Cargnel A; Colombo M; Hahn EG
J Hepatol; 1986; 2(3):379-88. PubMed ID: 3722792
[TBL] [Abstract][Full Text] [Related]
5. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
Lin DY; Chu CM; Sheen IS; Liaw YF
Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha 2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infection.
Zöhrens G; Armbrust T; Meyer Zum Büschenfelde KH; Ramadori G
Dig Dis Sci; 1994 Sep; 39(9):2007-13. PubMed ID: 8082511
[TBL] [Abstract][Full Text] [Related]
7. Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis.
Bentsen KD; Henriksen JH; Bendtsen F; Hørslev-Petersen K; Lorenzen I
Hepatology; 1990 Jun; 11(6):957-63. PubMed ID: 2365293
[TBL] [Abstract][Full Text] [Related]
8. Serum procollagen type III peptide levels in patients with acute viral hepatitis.
Annoni G; Donato MF; Cantaluppi C; Lampertico P; Cargnel A; Viganò P; Hahn EG; Colombo M
Ric Clin Lab; 1988; 18(1):37-44. PubMed ID: 3375738
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of the aminoterminal propeptide of type III procollagen and hyaluronan during resolving and nonresolving posttransfusion non-A, non-B hepatitis.
Mattsson L; Lindqvist U; Weiland O; Aberg B
Scand J Infect Dis; 1990; 22(1):11-7. PubMed ID: 2108489
[TBL] [Abstract][Full Text] [Related]
10. Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: relation to disease activity and effect of chemotherapy.
Hasselbalch H; Junker P; Hørslev-Petersen K; Lisse I; Bentsen KD
Am J Hematol; 1990 Jan; 33(1):18-26. PubMed ID: 2293759
[TBL] [Abstract][Full Text] [Related]
11. Aminoterminal propeptide of type III procollagen: a marker of disease activity in schistosomal patients.
Fayol V; Hassanein HI; el-Badrawy N; Ville G; Hartmann DJ
Eur J Clin Chem Clin Biochem; 1991 Nov; 29(11):737-41. PubMed ID: 1782280
[TBL] [Abstract][Full Text] [Related]
12. Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon.
Gabrielli GB; Casaril M; Stanzial AM; Colombari R; Pasino M; Corrocher R
Hepatogastroenterology; 2003; 50(54):2017-21. PubMed ID: 14696456
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of serum N-terminal propeptide of collagen type III levels in patients with chronic liver disease.
Weigand K; Zaugg PY; Frei A; Zimmermann A
Hepatology; 1984; 4(5):835-8. PubMed ID: 6479852
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
[TBL] [Abstract][Full Text] [Related]
15. Serum and urine analysis of the aminoterminal procollagen peptide type III by radioimmunoassay with antibody Fab fragments.
Rohde H; Langer I; Krieg T; Timpl R
Coll Relat Res; 1983 Sep; 3(5):371-9. PubMed ID: 6641123
[TBL] [Abstract][Full Text] [Related]
16. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C.
Guéchot J; Poupon RE; Giral P; Balkau B; Giboudeau J; Poupon R
J Hepatol; 1994 Mar; 20(3):388-93. PubMed ID: 8014451
[TBL] [Abstract][Full Text] [Related]
17. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
Risteli J; Søgaard H; Oikarinen A; Risteli L; Karvonen J; Zachariae H
Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204
[TBL] [Abstract][Full Text] [Related]
18. [Procollagen III and laminin in chronic viral hepatopathies].
Montalto G; Soresi M; Aragona F; Tripi S; Carroccio A; Anastasi G; Magliarisi C; Barresi E; Notarbartolo A
Presse Med; 1996 Jan; 25(2):59-62. PubMed ID: 8745719
[TBL] [Abstract][Full Text] [Related]
19. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.
Niemelä O; Risteli L; Sotaniemi EA; Risteli J
Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726
[TBL] [Abstract][Full Text] [Related]
20. Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease.
Misaki M; Shima T; Yano Y; Sumita Y; Kano U; Murata T; Watanabe S; Suzuki S
Clin Chem; 1990 Mar; 36(3):522-4. PubMed ID: 2311224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
